HYDROXYLAMINDERIVATE

Patent europeic · EP1692096 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1692096
Numer da la dumonda
EP04803725
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
10-12-2004
Publitgà
23-08-2006
Concedì
03-04-2013
Stritgà
23-07-2022
Motiv
Taxa annuala betg pajada
Classas IPC
C07C 239/12 (2006.01)
C07C 239/20 (2006.01)
A61K 31/13 (2006.01)
A61P 25/00 (2006.01)
Prioritad
EP 03028441 11.12.2003
Dumonda PCT
PCT/EP2004/014077 10.12.2004
Publicaziun PCT
WO2005/058800 30.06.2005
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-07-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.07.2022

  2. 17-05-2013

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 17.05.2013

  3. 03-04-2013

    Concedì

    Published in Swissreg on 03.04.2013

Partidas

Possessur

Newron Pharmaceuticals S.p.A.

Via L. Ariosto, 21, 20091 Bresso (MI), IT

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

CACCIA, Carla

I-21010 Cardano Al Campo, IT

GIROLA, Laura

I-21040 Gerenzano, IT

KALTOFEN, Petra, Karin

I-20144 Milano, IT

LOSI, Daniele

I-22069 Rovellasca, IT

SALVATI, Patricia

I-20020 Arese, IT

SELVA, Enrico

I-27027 Gropello Cairoli, IT

THALER, Florian

I-39012 Merano, IT

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.